UBS Group’s Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share JEMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,464
| Closed | -$9K | – | 11808 |
|
|
2022
Q3 | $9K | Buy |
1,464
+464
| +46% | +$3.04K | ﹤0.01% | 8670 |
|
|
2022
Q2 | $7K | Sell |
1,000
-66
| -6% | -$456 | ﹤0.01% | 8611 |
|
|
2022
Q1 | $7K | Sell |
1,066
-8,546
| -89% | -$62.1K | ﹤0.01% | 8917 |
|
|
2021
Q4 | $73K | Sell |
9,612
-21,363
| -69% | -$166K | ﹤0.01% | 6584 |
|
|
2021
Q3 | $247K | Sell |
30,975
-1,426
| -4% | -$11.5K | ﹤0.01% | 5173 |
|
|
2021
Q2 | $264K | Sell |
32,401
-1,216
| -4% | -$9.89K | ﹤0.01% | 5163 |
|
|
2021
Q1 | $266K | Buy |
33,617
+9,143
| +37% | +$71.3K | ﹤0.01% | 5284 |
|
|
2020
Q4 | $183K | Buy |
24,474
+19,721
| +415% | +$145K | ﹤0.01% | 5295 |
|
|
2020
Q3 | $36K | Buy |
4,753
+2,496
| +111% | +$18.6K | ﹤0.01% | 5879 |
|
|
2020
Q2 | $16K | Sell |
2,257
-5,887
| -72% | -$38.7K | ﹤0.01% | 6708 |
|
|
2020
Q1 | $50K | Buy |
8,144
+3,678
| +82% | +$31K | ﹤0.01% | 5836 |
|
|
2019
Q4 | $40K | Buy |
4,466
+466
| +12% | +$4.11K | ﹤0.01% | 6486 |
|
|
2019
Q3 | $35K | Sell |
4,000
-359
| -8% | -$3.21K | ﹤0.01% | 6405 |
|
|
2019
Q2 | $39K | Buy |
4,359
+359
| +9% | +$3.13K | ﹤0.01% | 6125 |
|
|
2019
Q1 | $35K | Sell |
4,000
-6,044
| -60% | -$50.9K | ﹤0.01% | 5817 |
|
|
2018
Q4 | $77K | Buy |
10,044
+7,522
| +298% | +$58.2K | ﹤0.01% | 5763 |
|
|
2018
Q3 | $21K | Sell |
2,522
-415
| -14% | -$3.47K | ﹤0.01% | 6776 |
|
|
2018
Q2 | $26K | Buy |
2,937
+2,327
| +381% | +$20.7K | ﹤0.01% | 6518 |
|
|
2018
Q1 | $5K | Sell |
610
-2,990
| -83% | -$27.8K | ﹤0.01% | 7263 |
|
|
2017
Q4 | $34K | Buy |
3,600
+1,400
| +64% | +$13.8K | ﹤0.01% | 6149 |
|
|
2017
Q3 | $22K | Buy |
+2,200
| New | +$22K | ﹤0.01% | 6386 |
|
UBS Group's JEMD Position: Q4 2022 in Review
UBS Group sold out of Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share (JEMD) in Q4 2022, closing a stake of 1,464 shares — an estimated $9K sold.
UBS Group first reported a position in JEMD in Q3 2017 and held it in 21 quarters. The position peaked at $266K in Q1 2021. 0 funds tracked by Wall St. Rank hold JEMD as of Q4 2022.
- UBS Group reported no remaining Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position as of Q4 2022 after selling out during the quarter.
- UBS Group sold 1,464 Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share shares in Q4 2022, an estimated $9K.
- UBS Group first reported a position in Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share in Q3 2017 and held it in 21 quarters.
- UBS Group's Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position peaked at $266K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share as of Q4 2022.
Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.